Justin Taft

1.8k total citations
11 papers, 340 citations indexed

About

Justin Taft is a scholar working on Immunology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Justin Taft has authored 11 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 4 papers in Molecular Biology and 3 papers in Infectious Diseases. Recurrent topics in Justin Taft's work include interferon and immune responses (5 papers), Systemic Lupus Erythematosus Research (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Justin Taft is often cited by papers focused on interferon and immune responses (5 papers), Systemic Lupus Erythematosus Research (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Justin Taft collaborates with scholars based in United States, Italy and Morocco. Justin Taft's co-authors include Dusan Bogunovic, Sofija Buta, Conor Gruber, Marta Martín-Fernández, John R. Mascola, Allan C. deCamp, Rui Kong, Anna Gazumyan, Robert T. Bailer and Kelli Greene and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Justin Taft

11 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Justin Taft United States 9 157 124 113 90 51 11 340
Miles Smith United States 10 125 0.8× 152 1.2× 86 0.8× 118 1.3× 31 0.6× 16 377
Matthew Woods Canada 13 168 1.1× 250 2.0× 83 0.7× 123 1.4× 26 0.5× 22 488
Marc Potempa United States 10 200 1.3× 129 1.0× 126 1.1× 151 1.7× 38 0.7× 15 456
Marie Lambelé United States 10 137 0.9× 136 1.1× 107 0.9× 231 2.6× 27 0.5× 11 425
Elisa Soprana Italy 11 222 1.4× 90 0.7× 48 0.4× 43 0.5× 35 0.7× 22 374
Mark Melchers Netherlands 11 286 1.8× 144 1.2× 99 0.9× 230 2.6× 20 0.4× 17 519
Matthias Hamdorf Germany 8 207 1.3× 253 2.0× 73 0.6× 195 2.2× 66 1.3× 12 537
Bianka Mußil France 8 74 0.5× 160 1.3× 60 0.5× 62 0.7× 26 0.5× 9 285
Matija Peterlin United States 8 321 2.0× 136 1.1× 69 0.6× 115 1.3× 45 0.9× 8 497
Ruth Simmons United Kingdom 8 90 0.6× 64 0.5× 113 1.0× 19 0.2× 51 1.0× 10 314

Countries citing papers authored by Justin Taft

Since Specialization
Citations

This map shows the geographic impact of Justin Taft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Justin Taft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Justin Taft more than expected).

Fields of papers citing papers by Justin Taft

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Justin Taft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Justin Taft. The network helps show where Justin Taft may publish in the future.

Co-authorship network of co-authors of Justin Taft

This figure shows the co-authorship network connecting the top 25 collaborators of Justin Taft. A scholar is included among the top collaborators of Justin Taft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Justin Taft. Justin Taft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Taft, Justin & Dusan Bogunovic. (2024). Traffic on the TLR expressway. The Journal of Experimental Medicine. 221(8). 1 indexed citations
2.
Tanaka, Shiho, C. Anders Olson, Christopher O. Barnes, et al.. (2022). Rapid identification of neutralizing antibodies against SARS-CoV-2 variants by mRNA display. Cell Reports. 38(6). 110348–110348. 13 indexed citations
3.
Jurczyszak, Denise, Lara Manganaro, Sofija Buta, et al.. (2022). ISG15 deficiency restricts HIV-1 infection. PLoS Pathogens. 18(3). e1010405–e1010405. 20 indexed citations
4.
Tanaka, Shiho, C. Anders Olson, Oleksandr Buzko, et al.. (2021). An ACE2 Triple Decoy that neutralizes SARS-CoV-2 shows enhanced affinity for virus variants. Scientific Reports. 11(1). 12740–12740. 42 indexed citations
5.
Gruber, Conor, Marta Martín-Fernández, Fatima Ailal, et al.. (2020). Homozygous STAT2 gain-of-function mutation by loss of USP18 activity in a patient with type I interferonopathy. The Journal of Experimental Medicine. 217(5). 71 indexed citations
6.
Taft, Justin, et al.. (2020). Type I IFN is siloed in endosomes. Proceedings of the National Academy of Sciences. 117(30). 17510–17512. 11 indexed citations
7.
Taft, Justin, et al.. (2019). Developing Broad-Spectrum Antivirals Using Porcine and Rhesus Macaque Models. The Journal of Infectious Diseases. 221(6). 890–894. 3 indexed citations
8.
Taft, Justin & Dusan Bogunovic. (2018). The Goldilocks Zone of Type I IFNs: Lessons from Human Genetics. The Journal of Immunology. 201(12). 3479–3485. 25 indexed citations
9.
Taft, Justin, et al.. (2017). Dioxin Exposure Alters Molecular and Morphological Responses to Thyroid Hormone in Xenopus laevis Cultured Cells and Prometamorphic Tadpoles. Toxicological Sciences. 161(1). 196–206. 13 indexed citations
10.
Park, Arnold, Patrick Hong, Sohui T. Won, et al.. (2016). Sendai virus, an RNA virus with no risk of genomic integration, delivers CRISPR/Cas9 for efficient gene editing. Molecular Therapy — Methods & Clinical Development. 3. 16057–16057. 47 indexed citations
11.
Kong, Rui, Mark K. Louder, Kshitij Wagh, et al.. (2014). Improving Neutralization Potency and Breadth by Combining Broadly Reactive HIV-1 Antibodies Targeting Major Neutralization Epitopes. Journal of Virology. 89(5). 2659–2671. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026